These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 1278093

  • 1. The mechanism of action of the thioureylene antithyroid drugs.
    Taurog A.
    Endocrinology; 1976 Apr; 98(4):1031-46. PubMed ID: 1278093
    [Abstract] [Full Text] [Related]

  • 2. Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs.
    Engler H, Taurog A, Luthy C, Dorris ML.
    Endocrinology; 1983 Jan; 112(1):86-95. PubMed ID: 6847836
    [Abstract] [Full Text] [Related]

  • 3. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland.
    Taurog A, Dorris ML, Doerge DR.
    Thyroid; 1996 Jun; 6(3):211-9. PubMed ID: 8837329
    [Abstract] [Full Text] [Related]

  • 4. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
    Engler H, Taurog A, Dorris ML.
    Endocrinology; 1982 Jan; 110(1):190-7. PubMed ID: 7053983
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A, Taurog A, Engler H, Dorris ML.
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [Abstract] [Full Text] [Related]

  • 6. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.
    Nagasaka A, Hidaka H.
    J Clin Endocrinol Metab; 1976 Jul; 43(1):152-8. PubMed ID: 947933
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
    Taurog A, Dorris ML, Guziec FS, Uetrecht JP.
    Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
    [Abstract] [Full Text] [Related]

  • 8. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.
    Taurog A, Dorris ML.
    Endocrinology; 1989 Jun; 124(6):3038-42. PubMed ID: 2656250
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of inactivation of thyroid peroxidase by thioureylene drugs.
    Engler H, Taurog A, Nakashima T.
    Biochem Pharmacol; 1982 Dec 01; 31(23):3801-6. PubMed ID: 6186257
    [Abstract] [Full Text] [Related]

  • 10. The selenium analog of 6-propylthiouracil. Measurement of its inhibitory effect on type I iodothyronine deiodinase and of its antithyroid activity.
    Taurog A, Dorris ML, Hu WX, Guziec FS.
    Biochem Pharmacol; 1995 Mar 01; 49(5):701-9. PubMed ID: 7887985
    [Abstract] [Full Text] [Related]

  • 11. Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles.
    Sugawara M, Sugawara Y, Wen K.
    Thyroid; 1999 May 01; 9(5):513-8. PubMed ID: 10365684
    [Abstract] [Full Text] [Related]

  • 12. The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.
    Davidson B, Soodak M, Neary JT, Strout HV, Kieffer JD, Mover H, Maloof F.
    Endocrinology; 1978 Sep 01; 103(3):871-82. PubMed ID: 744122
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T, Taurog A, Riesco G.
    Endocrinology; 1978 Dec 01; 103(6):2187-97. PubMed ID: 748042
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of 35S- and 14C-labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo.
    Taurog A, Dorris ML, Guziec FS.
    Endocrinology; 1989 Jan 01; 124(1):30-9. PubMed ID: 2535809
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase.
    Taurog A, Dorris ML, Doerge DR.
    Arch Biochem Biophys; 1996 Jun 01; 330(1):24-32. PubMed ID: 8651700
    [Abstract] [Full Text] [Related]

  • 16. Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
    Sugawara M.
    J Clin Endocrinol Metab; 1985 Jun 01; 60(6):1069-75. PubMed ID: 3838997
    [Abstract] [Full Text] [Related]

  • 17. Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat.
    Paul KB, Hedge JM, Macherla C, Filer DL, Burgess E, Simmons SO, Crofton KM, Hornung MW.
    Toxicology; 2013 Oct 04; 312():97-107. PubMed ID: 23959146
    [Abstract] [Full Text] [Related]

  • 18. Mechanism for the anti-thyroid action of minocycline.
    Doerge DR, Divi RL, Deck J, Taurog A.
    Chem Res Toxicol; 1997 Jan 04; 10(1):49-58. PubMed ID: 9074802
    [Abstract] [Full Text] [Related]

  • 19. Thiourea and cyanamide as inhibitors of thyroid peroxidase: the role of iodide.
    Davidson B, Soodak M, Strout HV, Neary JT, Nakamura C, Maloof F.
    Endocrinology; 1979 Apr 04; 104(4):919-24. PubMed ID: 436767
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of iodide-dependent catalatic activity of thyroid peroxidase and lactoperoxidase.
    Magnusson RP, Taurog A, Dorris ML.
    J Biol Chem; 1984 Jan 10; 259(1):197-205. PubMed ID: 6706930
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.